Retinal vein thrombosis: The Internist's role in the etiologic and therapeutic management

Alejandro Garcia-Horton; Fatimah Al-Ani; Alejandro Lazo-Langner

doi:10.1016/j.thromres.2016.11.004

Retinal vein thrombosis: The Internist's role in the etiologic and therapeutic management

Thromb Res. 2016 Dec:148:118-124. doi: 10.1016/j.thromres.2016.11.004. Epub 2016 Nov 5.

Authors

Alejandro Garcia-Horton¹, Fatimah Al-Ani¹, Alejandro Lazo-Langner²

Affiliations

¹ Department of Medicine, Division of Hematology, University of Western Ontario, London, ON, Canada.
² Department of Medicine, Division of Hematology, University of Western Ontario, London, ON, Canada; Department of Epidemiology and Biostatistics, University of Western Ontario, London, ON, Canada. Electronic address: alejandro.lazolangner@lhsc.on.ca.

PMID: 27838473
DOI: 10.1016/j.thromres.2016.11.004

Abstract

Retinal vein occlusion is a common and important cause of vision loss. In general, knowledge about this condition is scant within an internist's practice but the condition is relevant because of its association with other chronic ailments. A diagnosis of RVO should prompt the investigation of conditions needing chronic management in these patients. In this review we summarize the clinical presentation of RVO, its classification, associated risk factors, and treatment focused in the internist's scope of practice.

Keywords: Anticoagulation; Pathophysiology; Retinal vein occlusion; Treatment.

Publication types

Review

MeSH terms

Anticoagulants / therapeutic use
Heparin, Low-Molecular-Weight / therapeutic use
Humans
Platelet Aggregation Inhibitors / therapeutic use
Prognosis
Retinal Vein / drug effects
Retinal Vein / pathology*
Retinal Vein Occlusion / diagnosis*
Retinal Vein Occlusion / drug therapy*
Retinal Vein Occlusion / epidemiology
Retinal Vein Occlusion / pathology
Warfarin / therapeutic use

Substances

Anticoagulants
Heparin, Low-Molecular-Weight
Platelet Aggregation Inhibitors
Warfarin